NASDAQ : SPRO
Spero Therapeutics, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 1.06 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 61.73M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Spero Therapeutics, Inc. (SPRO) reported revenue of 47.00M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 47.00M | 66.80M | 47.98M | 103.78M | 53.51M | 18.26M |
| Cost of Revenue | 20.53M | 38.47M | 96.76M | 51.44M | 47.59M | 64.53M |
| Gross Profit | 26.46M | 28.34M | -48.78M | 52.34M | 5.92M | -46.27M |
| Selling, General & Admin | 19.85M | 21.18M | 23.70M | 25.55M | 36.48M | 41.70M |
| Operating Expenses | 19.85M | 21.18M | 23.70M | 25.55M | 36.48M | 41.70M |
| Operating Income | 6.61M | 7.16M | -72.48M | 26.79M | -30.57M | -87.97M |
| Interest Expense | -2.60M | -1.94M | ||||
| Interest & Investment Income | 1.62M | 2.51M | 4.74M | 3.94M | 1.11M | 346.00K |
| Other Non Operating Income (Expenses) | -2.00K | 7.00K | 60.00K | -14.00K | 862.00K | -191.00K |
| EBT Excluding Unusual Items | 8.23M | 9.68M | -67.69M | 30.71M | -31.20M | -89.76M |
| Merger & Restructuring Charges | -258.00K | -877.00K | -11.63M | |||
| Asset Writedown | -587.00K | -587.00K | -5.31M | |||
| Other Unusual Items | -3.58M | |||||
| Pretax Income | 7.64M | 8.83M | -68.57M | 25.40M | -46.41M | -89.76M |
| Income Tax Expense | 261.00K | 261.00K | 2.60M | |||
| Earnings From Continuing Operations | 7.38M | 8.57M | -68.57M | 22.81M | -46.41M | -89.76M |
| Net Income | 7.38M | 8.57M | -68.57M | 22.81M | -46.41M | -89.76M |
| Net Income to Common | 7.38M | 8.57M | -68.57M | 22.81M | -46.41M | -89.76M |
| Shares Outstanding (Basic) | 56.98M | 56.02M | 54.04M | 52.70M | 37.59M | 30.90M |
| Shares Outstanding (Diluted) | 60.00M | 59.04M | 54.04M | 52.99M | 37.59M | 30.90M |
| EPS (Basic) | 0.13 | 0.15 | -1.27 | 0.43 | -1.23 | -2.91 |
| EPS (Diluted) | 0.13 | 0.15 | -1.27 | 0.43 | -1.23 | -2.91 |
| Free Cash Flow | 19.58M | -12.62M | -23.44M | -32.99M | -7.73M | -64.35M |
| Free Cash Flow Per Share | 0.33 | -0.21 | -0.43 | -0.62 | -0.21 | -2.08 |
| Gross Margin | 56.31% | 42.42% | -101.67% | 50.43% | 11.06% | -253.45% |
| Operating Margin | 14.07% | 10.72% | -151.08% | 25.81% | -57.12% | -481.87% |
| Profit Margin | 15.71% | 12.83% | -142.91% | 21.98% | -86.74% | -491.65% |
| Free Cash Flow Margin | 41.66% | -18.90% | -48.86% | -31.79% | -14.45% | -352.47% |
| EBITDA | 7.16M | -72.48M | 27.15M | -29.70M | -87.33M | |
| EBITDA Margin | 10.72% | -151.08% | 26.16% | -55.50% | ||
| D&A For EBITDA | 2.00K | 2.00K | 367.00K | 869.00K | 646.00K | |
| EBIT | 6.61M | 7.16M | -72.48M | 26.79M | -30.57M | -87.97M |
| EBIT Margin | 14.07% | 10.72% | -151.08% | 25.81% | -57.12% | |
| Effective Tax Rate | 3.41% | 2.96% | 10.23% | |||
| Revenue as Reported | 47.00M | 66.80M | 47.98M | 103.78M | 53.51M | 18.26M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 50.77M | 40.27M | 52.89M | 76.33M | 109.11M | 112.58M |
| Short-Term Investments | 33.82M | |||||
| Cash & Short-Term Investments | 50.77M | 40.27M | 52.89M | 76.33M | 109.11M | 146.40M |
| Accounts Receivable | 25.36M | 49.39M | 49.15M | |||
| Other Receivables | 25.00K | 28.00K | 3.08M | 1.54M | 1.08M | 2.64M |
| Receivables | 25.00K | 25.39M | 52.48M | 50.70M | 1.08M | 2.64M |
| Prepaid Expenses | 785.00K | 1.63M | 1.91M | 4.18M | 3.38M | 8.83M |
| Total Current Assets | 51.58M | 67.29M | 107.28M | 131.21M | 113.57M | 157.87M |
| Property, Plant & Equipment | 1.03M | 1.48M | 3.11M | 4.16M | 5.49M | 7.56M |
| Long-Term Accounts Receivable | 46.59M | |||||
| Other Long-Term Assets | 153.00K | 153.00K | 153.00K | 435.00K | 5.74M | 5.64M |
| Total Assets | 52.77M | 68.92M | 110.54M | 182.39M | 124.80M | 171.07M |
| Accounts Payable | 155.00K | 693.00K | 7.31M | 1.38M | 617.00K | 1.10M |
| Accrued Expenses | 6.11M | 5.58M | 17.27M | 6.56M | 8.53M | 14.35M |
| Current Portion of Leases | 2.00M | 1.96M | 1.75M | 1.72M | 1.69M | 1.36M |
| Current Income Taxes Payable | 163.00K | 383.00K | 174.00K | 387.00K | ||
| Current Unearned Revenue | 258.00K | 22.12M | 27.11M | 10.37M | 1.86M | |
| Other Current Liabilities | 456.00K | 448.00K | ||||
| Total Current Liabilities | 8.43M | 8.87M | 49.07M | 37.15M | 21.65M | 18.67M |
| Long-Term Debt | 48.41M | |||||
| Long-Term Leases | 43.00K | 939.00K | 2.55M | 3.83M | 4.96M | 5.97M |
| Long-Term Unearned Revenue | 12.79M | 34.43M | 22.17M | 8.79M | ||
| Other Long-Term Liabilities | 91.00K | 91.00K | 87.00K | 96.00K | 940.00K | |
| Total Liabilities | 8.56M | 9.90M | 64.42M | 75.50M | 48.87M | 82.78M |
| Common Stock | 58.00K | 56.00K | 55.00K | 53.00K | 52.00K | 32.00K |
| Additional Paid-In Capital | 511.97M | 510.03M | 505.71M | 497.91M | 489.76M | 455.72M |
| Retained Earnings | -467.82M | -451.07M | -459.64M | -391.07M | -413.88M | -367.46M |
| Comprehensive Income & Other | -2.00K | |||||
| Total Common Equity | 44.20M | 59.02M | 46.12M | 106.89M | 75.93M | 88.29M |
| Shareholders' Equity | 44.20M | 59.02M | 46.12M | 106.89M | 75.93M | 88.29M |
| Total Liabilities & Equity | 52.77M | 68.92M | 110.54M | 182.39M | 124.80M | 171.07M |
| Total Debt | 2.04M | 2.90M | 4.30M | 5.54M | 6.65M | 55.75M |
| Net Cash (Debt) | 48.73M | 37.37M | 48.59M | 70.79M | 102.46M | 90.65M |
| Net Cash Per Share | 0.81 | 0.63 | 0.90 | 1.34 | 2.73 | 2.93 |
| Filing Date Shares Outstanding | 58.23M | 57.89M | 55.90M | 53.87M | 52.57M | 32.76M |
| Total Common Shares Outstanding | 58.15M | 56.41M | 54.59M | 53.00M | 52.46M | 32.39M |
| Working Capital | 43.16M | 58.42M | 58.20M | 94.06M | 91.92M | 139.20M |
| Book Value Per Share | 0.76 | 1.05 | 0.84 | 2.02 | 1.45 | 2.73 |
| Tangible Book Value | 44.20M | 59.02M | 46.12M | 106.89M | 75.93M | 88.29M |
| Tangible Book Value Per Share | 0.76 | 1.05 | 0.84 | 2.02 | 1.45 | 2.73 |
| Machinery | 1.55M | 1.55M | 1.76M | |||
| Leasehold Improvements | 1.64M | 1.64M | 1.64M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | 7.38M | 8.57M | -68.57M | 22.81M | -46.41M | -89.76M |
| Depreciation & Amortization | 2.00K | 367.00K | 869.00K | 646.00K | ||
| Asset Writedown & Restructuring Costs | 587.00K | 587.00K | 5.31M | 635.00K | ||
| Loss (Gain) From Sale of Investments | 13.00K | 251.00K | ||||
| Stock-Based Compensation | 3.99M | 4.33M | 7.79M | 7.93M | 9.12M | 9.43M |
| Other Operating Activities | 950.00K | 1.05M | 1.04M | 969.00K | 5.96M | 2.22M |
| Change in Accounts Receivable | 24.45M | 24.03M | 46.35M | -95.74M | 1.55M | 3.05M |
| Change in Accounts Payable | -625.00K | -6.61M | 5.93M | 761.00K | -484.00K | -53.00K |
| Change in Unearned Revenue | -18.01M | -34.66M | -26.62M | 29.01M | 21.89M | 10.64M |
| Change in Income Taxes | 209.00K | -213.00K | 387.00K | 782.00K | ||
| Change in Other Net Operating Assets | 847.00K | -10.12M | 10.84M | -4.79M | -868.00K | -1.56M |
| Operating Cash Flow | 19.58M | -12.62M | -23.44M | -32.99M | -7.73M | -64.35M |
| Sale of Property, Plant & Equipment | 39.00K | |||||
| Investment in Securities | 33.81M | 7.63M | ||||
| Investing Cash Flow | 33.81M | 7.67M | ||||
| Issuance of Common Stock | 221.00K | 24.93M | 36.82M | |||
| Other Financing Activities | -54.48M | 47.23M | ||||
| Financing Cash Flow | 221.00K | -29.55M | 84.05M | |||
| Net Cash Flow | 19.58M | -12.62M | -23.44M | -32.77M | -3.48M | 27.38M |
| Free Cash Flow | 19.58M | -12.62M | -23.44M | -32.99M | -7.73M | -64.35M |
| Free Cash Flow Margin | 41.66% | -18.90% | -48.86% | -31.79% | -14.45% | -352.47% |
| Free Cash Flow Per Share | 0.33 | -0.21 | -0.43 | -0.62 | -0.21 | -2.08 |
| Levered Free Cash Flow | 28.85M | -4.25M | -25.13M | -9.90M | -1.08M | -41.44M |
| Unlevered Free Cash Flow | 28.85M | -4.25M | -25.13M | -9.90M | 545.62K | -40.22M |
| Cash Income Tax Paid | 2.21M | |||||
| Change in Working Capital | 6.67M | -27.16M | 36.28M | -70.38M | 22.09M | 12.86M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 61.73M | 131.27M | 56.15M | 77.91M | 89.57M | 517.50M |
| Enterprise Value | 13.00M | 86.01M | -15.51M | -10.09M | 46.03M | 401.32M |
| Last Close Price | 1.06 | 2.33 | 1.03 | 1.47 | 1.73 | 16.01 |
| PE Ratio | 8.30 | 15.31 | 3.42 | |||
| Forward PE | 4.88 | |||||
| PS Ratio | 1.31 | 1.97 | 1.17 | 0.75 | 1.67 | 28.35 |
| PB Ratio | 1.39 | 2.22 | 1.22 | 0.73 | 1.18 | 5.86 |
| P/TBV Ratio | 1.40 | 2.22 | 1.22 | 0.73 | 1.18 | 5.86 |
| EV/Sales Ratio | 0.28 | 1.29 | 0.86 | 21.98 | ||
| EV/EBITDA Ratio | 12.01 | |||||
| EV/EBIT Ratio | 1.97 | 12.01 | ||||
| Debt / Equity Ratio | 0.05 | 0.05 | 0.09 | 0.05 | 0.09 | 0.63 |
| Debt / EBITDA Ratio | 0.25 | 0.34 | 0.19 | |||
| Debt / FCF Ratio | 0.10 | |||||
| Net Debt / Equity Ratio | -1.10 | -0.63 | -1.05 | -0.66 | -1.35 | -1.03 |
| Net Debt / EBITDA Ratio | -5.22 | 0.67 | -2.61 | 3.45 | 1.04 | |
| Net Debt / FCF Ratio | -2.49 | 2.96 | 2.07 | 2.15 | 13.25 | 1.41 |
| Asset Turnover | 0.82 | 0.74 | 0.33 | 0.68 | 0.36 | 0.11 |
| Quick Ratio | 6.03 | 7.40 | 2.15 | 3.42 | 5.09 | 7.98 |
| Current Ratio | 6.12 | 7.59 | 2.19 | 3.53 | 5.25 | 8.46 |
| Return on Equity (ROE) | 19.17% | 16.30% | -89.62% | 24.95% | -56.53% | -81.47% |
| Return on Assets (ROA) | 7.19% | 4.99% | -30.93% | 10.90% | -12.91% | -33.88% |
| Return on Invested Capital (ROIC) | 32.09% | 66.61% | ||||
| Return on Capital Employed (ROCE) | 14.90% | 11.90% | -117.90% | 18.40% | -29.60% | -57.70% |
| Earnings Yield | 12.05% | 6.53% | -122.10% | 29.27% | -51.82% | -17.34% |
| FCF Yield | 31.72% | -9.62% | -41.75% | -42.35% | -8.63% | -12.43% |
| Buyback Yield / Dilution | -9.05% | -9.25% | -1.98% | -40.98% | -21.65% | -38.01% |